3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
52
Ovarian Neoplasms
40
Multiple Myeloma
20
Fallopian Tube Neoplasms
13
Lymphoma
12
Sarcoma
11
Carcinoma, Ovarian Epithelial
11
Triple Negative Breast Neoplasms
8
Recurrence
8
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
6
Neoplasms, Plasma Cell
5
Sarcoma, Ewing
4
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Mantle-Cell
4
Burkitt Lymphoma
4
Rhabdomyosarcoma
3
Osteosarcoma
3
Lymphoma, T-Cell, Peripheral
3
Leiomyosarcoma
3
Breast Neoplasms, Male
3
Uterine Cervical Neoplasms
2
Solid Tumors
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Interventions
Radiotherapy
7
Brachytherapy
6
Surveys and Questionnaires
4
Magnetic Resonance Spectroscopy
4
durvalumab
3
Radiosurgery
3
Methods
3
tremelimumab
2
aldesleukin
2
Topotecan
2
Radiation
2
Palliative Care
2
Paclitaxel
2
Immunoglobulin G
2
Gemcitabine
2
Early Intervention, Educational
2
Disulfides
2
Dehydroepiandrosterone
2
Counseling
2
Capecitabine
2
Bevacizumab
2
Behavior Therapy
2
Adoptive Transfer
2
zimberelimab
1
temsirolimus
1
talazoparib
1
rocakinogene sifuplasmid
1
liposomal doxorubicin
1
fludarabine phosphate
1
dostarlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Vaginal Neoplasms
×
liposomal doxorubicin
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled